From: Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands
(n = 3.371) | Complication rates all ages | Complication rates (%) per age group |  | Corrected rate (%) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 | (n) | (%) | (95% CI) | <60 | 60-64 | >65 | All | (95% CI) | >60 | (95% CI) |
Upper respiratory tract. ENT complications | ||||||||||
Otitis media | 203 | 6.02 | (5.27-6.88) | 6.0 | 5.2 | 6.3 | 1.77* | (0.90-2.64) | 3.55* | (1.73-5.37) |
Upper respiratory tract infection | 350 | 10.38 | (9.40-11.46) | 8.9 | 12.3 | 14.7 | 5.55* | (4.45-6.63) | 7.96* | (5.24-10.69) |
Sum of complications | 553 | 16.40 | (15.19-17.69) | 14.9 | 17.5 | 21.0 | 7.32 | Â | 11.51 | Â |
Total number of patientsa | 501 | 14.86 | (13.70-16.10) | Â | Â | Â | Â | Â | Â | Â |
Eye complications | ||||||||||
Keratitis | 13 | 0.39 | (0.23-0.66) | 0.3 | 0.0 | 0.8 | 0.39* | (0.18-0.59) | 0.64* | (0.13-1.16) |
Conjunctivitis | 48 | 1.42 | (1.08-1.88) | 1.4 | 2.4 | 1.4 | 1.42* | (1.02-1.82) | 1.08* | (0.14-2.01) |
Problems Eyelids | 96 | 2.85 | (2.34-3.47) | 2.5 | 4.7 | 3.6 | 2.83* | (2.26-3.39) | 3.76* | (2.50-5.02) |
Visus | 18 | 0.53 | (0.34-0.84) | 0.4 | 0.9 | 0.8 | 0.53* | (0.29-0.78) | 0.86* | (0.27-1.45) |
Sum of complications | 175 | 5.19 | (4.49-5.99) | 4.6 | 8.0 | 6.6 | 5.17 | Â | 6.34 | Â |
Total number of patientsa | 147 | 4.36 | (3.72-5.10) | Â | Â | Â | Â | Â | Â | Â |
Lower respiratory tract complications | ||||||||||
Pneunomia | 15 | 0.44 | (0.27-0.73) | 0.2 | 0.9 | 1.0 | 0.30* | (0.07-0.53) | 0.65 | (−0.08-1.37) |
Bronchitis | 50 | 1.48 | (1.13-1.95) | 1.3 | 2.8 | 1.8 | 0.65* | (0.21-1.08) | 0.21 | (−1.53-1.11) |
Sum of complications | 65 | 1.93 | (1.52-2.45) | 1.5 | 3.7 | 2.8 | 0.95 | Â | 0.86 | Â |
Total number of patientsa | 64 | 1.90 | (1.49 2.42) | Â | Â | Â | Â | Â | Â | Â |
Skin infectious/cutaneous complications | ||||||||||
Phlegmon | 13 | 0.39 | (0.23-0.66) | 0.4 | 0.0 | 0.6 | 0.29* | (0.08-0.51) | 0.22 | (−0.30-0.73) |
Pyoderma | 13 | 0.39 | (0.23-0.66) | 0.4 | 0.0 | 0.4 | 0.30* | (0.08-0.51) | 0.11 | (−0.36-0.58) |
Abscess | 30 | 0.89 | (0.62-1.27) | 0.8 | 1.9 | 0.8 | 0.57* | (0.24-0.90) | 0.86* | (0.13-1.59) |
Skin infection | 32 | 0.95 | (0.67-1.34) | 0.9 | 0.0 | 1.4 | 0.77* | (0.43-1.10) | 0.86* | (0.13-1.59) |
Cellulitis | 21 | 0.62 | (0.41-0.95) | 0.6 | 1.4 | 0.4 | 0.55* | (0.28-0.82) | 0.43 | (−0.16-1.02) |
Scar Tissue | 46 | 1.36 | (1.02-1.82) | 1.3 | 0.5 | 1.9 | 0.57* | (0.15-0.99) | 0.97* | (0.01-1.93) |
Impetigo | 112 | 3.32 | (2.77-3.98) | 3.9 | 1.4 | 1.8 | 2.65* | (2.03-3.27) | 1.61* | (0.75-2.47) |
Sum of complications | 267 | 7.92 | (7.06-8.88) | 8.3 | 5.2 | 7.3 | 5.7 | Â | 5.06 | Â |
Total number of patientsa | 234 | 6.94 | (6.13 7.85) | Â | Â | Â | Â | Â | Â | Â |
PHN | ||||||||||
PHN | 195 | 5.78 | (5.05 6.62) | 3.4 | 8.0 | 13.1 | 5.78* | (5.00-6.57) | 11.92* | (9.84-14.00) |
Neurologic complications other than PHN | ||||||||||
Syncope | 27 | 0.80 | (0.55-1.16) | 0.5 | 0.5 | 1.8 | 0.38* | (0.06-0.70) | 1.50* | (0.72-2.29) |
Neuralgia (Trigeminal) | 75 | 2.22 | (1.78-2.78) | 1.8 | 2.8 | 3.5 | 2.21* | (1.71-2.71) | 3.33* | (2.18-4.48) |
Meningitis | 2 | 0.15 | (0.02-0.22) | 0.2 | 0.0 | 0.1 | 0.14 | (−0.03-0.14) | 0.11 | (−0.10-0.32) |
Ataxia (Cerebellitis) | 1 | 0.03 | (0.01-0.17) | 0.04 | 0.0 | 0.0 | 0.03 | (−0.03-0.09) | 0.00 |  |
Movement and stability dysfunct. | 6 | 0.18 | (0.08-0.39) | 0.1 | 0.0 | 0.6 | 0.18* | (0.04-0.32) | 0.43* | (0.01-0.85) |
Vertigo | 97 | 2.88 | (2.36-3.50) | 2.3 | 1.9 | 5.0 | 2.36* | (1.79-2.94) | 3.12* | (1.64-4.59) |
Facial palsy | 33 | 0.98 | (0.70-1.37) | 0.8 | 0.0 | 1.8 | 0.98* | (0.65-1.31) | 1.40* | (0.64-2.15) |
Coma | 1 | 0.03 | (0.01-0.17) | 0.0 | 0.0 | 0.0 | 0.03 | (−0.03-0.09) | 0.00 |  |
Pain face | 24 | 0.71 | (0.48-1.06) | 0.5 | 0.9 | 1.3 | 0.69* | (0.41-0.97) | 1.18* | (0.49-1.88) |
Sum of complications | 266 | 7.89 | (7.03-8.85) | 6.24 | 6.1 | 14.1 | 7.00 | Â | 11.07 | Â |
Total number of patientsa | 258 | 7.65 | (6.80-8.60) | Â | Â | Â | Â | Â | Â | Â |
Gastrointestinal tract complications | ||||||||||
Stomatitis | 9 | 0.27 | (0.14-0.51) | 0.2 | 0.5 | 0.3 | 0.24* | (0.06-0.41) | 0.43* | (0.01-0.85) |
Gastroenteritis | 52 | 1.54 | (1.18-2.02) | 1.2 | 3.3 | 2.2 | 0.63* | (0.18-1.07) | 1.18 | (−0.05-2.42) |
Pancreatitis | 10 | 0.30 | (0.16-0.55) | 0.1 | 1.9 | 0.6 | 0.25* | (0.07-0.44) | 0.86* | (0.27-1.45) |
Sum of complications | 71 | 2.11 | (1.67-2.65) | 1.5 | 5.7 | 3.1 | 1.12 | Â | 2.47 | Â |
Total number of patientsa | 66 | 1.96 | (1.54-2.48) | Â | Â | Â | Â | Â | Â | Â |
Complications due to (systemic) bacterial infections | ||||||||||
Sepsis | 1 | 0.03 | (0.01-0.17) | 0.04 | 0.0 | 0.0 | 0.02 | (−0.04-0.08) | 0.00 |  |
Pyogen arthritis | 3 | 0.09 | (0.03-0.26) | 0.08 | 0.5 | 0.0 | 0.09 | (−0.01-0.19) | 0.11 | (−0.10-0.32) |
Sum of complications | 4 | 0.12 | (0.05-0.30) | 0.1 | 0.5 | 0.0 | 0.11 | Â | 0.11 | Â |
Total number of patientsa | 4 | 0.12 | (0.05-0.30) | Â | Â | Â | Â | Â | Â | Â |
Symptoms | ||||||||||
Coughing | 241 | 7.15 | (6.33-8.07) | 6.1 | 7.5 | 10.7 | 3.29* | (2.36-4.22) | 6.88* | (4.66-9.11) |
Snivelling | 26 | 0.77 | (0.53-1.13) | 0.7 | 0.5 | 1.0 | 0.46* | (0.15-0.77) | 0.54 | (−0.16-1.23) |
Fever | 703 | 20.85 | (19.52-22.26) | 20.5 | 20.8 | 22.0 | 12.41* | (10.95-13.85) | 16.23* | (13.21-19.25) |
Fatigue | 148 | 4.39 | (3.75-5.14) | 4.2 | 1.9 | 5.8 | 2.80* | (2.08-3.52) | 3.23* | (1.60-4.85) |
Emesis/Vomiting | 121 | 3.59 | (3.01-4.27) | 3.0 | 3.3 | 5.6 | 2.15* | (1.49-2.81) | 4.30* | (2.79-5.81) |
Pruritis/Itching | 1.005 | 29.81 | (28.29-31.38) | 31.7 | 17.9 | 26.8 | 22.64* | (21.03-24.23) | 17.20* | (13.95-20.46) |
Skin rash/Exanthema | 400 | 11.87 | (10.82-13.00) | 11.2 | 13.2 | 13.6 | 11.00* | (9.89-12.09) | 12.78* | (10.52-15.05) |
Dehydration/Diarreah | 106 | 3.14 | (2.61-3.79) | 2.6 | 2.4 | 5.3 | 1.58* | (1.03-2.27) | 3.76* | (2.29-5.23) |